This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. jumped 10.5% to $7.39 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.5% to 16,708.05 and the Dow Jones Industrial Average rising 1.1% to 39,606.57.
This was the stock's fourth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 88.1% below its 52-week high of $61.90, which the company reached on July 31st.
The stock outperformed some of its competitors, as Vanda Pharmaceuticals Inc. fell 1.8% to $4.33, Fortress Biotech Inc. rose 3.3% to $1.58, and Viking Therapeutics Inc. rose 1.22% to $25.79.
Trading volume totaled 208,797, compared to the 50-day average of 236,332.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 23, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。